ClinicalTrials.gg
CompletedNCT03177577Updated Nov 10, 2026Results posted

Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis

An interventional study of Splint and Splint with strengthening exercises in Thumb Osteoarthritis and First Dorsal Interosseous Strengthening, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Dec 2016, registered Jun 2017).
Updated Nov 10, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Osteoarthritis by Massachusetts General Hospital — 3 open to participants now, 4 under way, 1 of them phase 3. Osteoarthritis · Massachusetts General Hospital.

Enrollment
2nd of 10
160 · median 85
Started
2016
with 2 others
No phase
8 of 13
1 open now
Registered
9th of 13
by date

Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, this one is the 2nd largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2016, is one of 8 with no phase, and was the 9th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

3 of the 13 studies in Osteoarthritis by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Osteoarthritis by Massachusetts General Hospital, or all of them as a file.
02

Study summary

To determine the effect of first dorsal interosseus (FDI) strengthening in patients with thumb carpometacarpal (CMC) osteoarthritis.

Read the detailed description

Thumb CMC osteoarthritis is a normal part of aging. Most patients are able to adapt to symptoms of pain and disability, other patients might benefit from non-operative interventions; e.g. splinting, corticosteroid injections, pain medication, and multiple hand exercises.

The dorsal ligament complex is one of the components for stability of the thumb CMC joint. These ligaments specifically create stability for pinch and grip during the final phase of opposition. Both, the opponens pollicis (OP) and the first dorsal interosseous (FDI) play a key role in centralizing the metacarpal on the trapezium. A retrospective study showed that a dynamic stability modeled approach, including targeting the FDI, reduced pain and improved function in patients with thumb CMC osteoarthritis. Recently, another study demonstrated that reduction of radial subluxation - the thumb metacarpal versus the trapezium CMC joint - was achieved by contraction of the dynamic stabilizers of the healthy hand, specifically with the focus on the FDI.

More clinical research is needed to determine if there are efficacious (effective and low-cost) evidence-based exercise programs for pain reduction and functional improvement in patients with thumb CMC osteoarthritis. The investigators are interested in the effect of FDI strengthening in patients with thumb CMC osteoarthritis. Therefore, the investigators hypothesized that there is no difference in the change of lateral pinch strength at 12 weeks between patients treated with a splint versus patients treated with a splint and FDI strengthening for thumb CMC osteoarthritis. We also tested the same hypothesis for 3-point chuck strength, VAS for pain, and PROMIS Upper Extremity CAT.

03

Conditions studied

  • Thumb Osteoarthritis
  • First Dorsal Interosseous Strengthening

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years old
  • English-speaking
  • Splint treatment for thumb carpometacarpal (CMC) osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years old
  • Rheumatoid Arthritis or post-traumatic carpometacarpal (CMC) osteoarthritis
  • Patients that received a injection during the appointment for treatment of thumb carpometacarpal (CMC) osteoarthritis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
160 participants (actual)

Study arms

  • Placebo comparator
    Splint Only

    Subjects with carpometacarpal (CMC) osteoarthritis treated by splinting of their thumb.

    Device: Splint

  • Active comparator
    Splint with first dorsal interosseous (FDI) strengthening

    Subjects with carpometacarpal (CMC) osteoarthritis treated by splinting of their thumb combined with first dorsal interosseous (FDI) strengthening stabilization exercises.

    Device: Splint with strengthening exercises

Interventions

  • DeviceSplint

    Subjects will use a splint custom-made by Massachusetts General Hospital Occupational Therapists as part of standard care for treatment of carpometacarpal (CMC) osteoarthritis.

  • DeviceSplint with strengthening exercises

    Subjects will use a splint custom-made by Massachusetts General Hospital Occupational Therapists as part of standard care for treatment of carpometacarpal (CMC) osteoarthritis and will also be taught two first dorsal interosseous (FDI) strengthening exercises.

06

What researchers measure

Primary outcomes

  1. Difference in Lateral Pinch Strength at 12 Weeks

    The investigators will measure lateral pinch strength by placing a pinch meter between the pad of the thumb and lateral surface of the index finger. The investigators will compare the change in lateral pinch strength between the two cohorts after 12 weeks of treatment.

    Time frame: At enrollment and 12 week follow up

Secondary outcomes

  1. Difference in 3-point Chuck Strength at 12 Weeks

    Investigators will measure the pinch strength by placing a pinch meter between the pad of the thumb and pad of the index and middle finger. The investigators will compare the change in 3 point chuck strength between the two cohorts after 12 weeks of treatment.

    Time frame: At enrollment and 12 week follow up

  2. Visual Analog Scale (VAS) for Pain

    The Visual Analog Scale for Pain measures the amount of pain on a scale from 0, no pain, to 10, worst possible pain. The investigators will compare the change in pain between the two cohorts after 12 weeks of treatment.

    Time frame: At enrollment and 12 week follow up

  3. Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks

    A computerized assessment of depression measured at enrollment. The average T score of the U.S. population is 50 with a standard deviation of 10, so the T score reported compares the study population to the U.S. population, where a T score greater than 50 is worse than the average and a T score less than 50 is better than the average. The investigators will compare the change in PROMIS Upper Extremity between the two cohorts after 12 weeks of treatment.

    Time frame: At Enrollment and 12 week follow up

07

Results

Posted Nov 10, 2026

Participant flow

Participant flow — Overall Study
MilestoneSplint OnlySplint With First Dorsal Interosseous (FDI) Strengthening
Started8080
Completed4443
Not completed3637

Outcome measures

SecondaryDifference in 3-point Chuck Strength at 12 Weeks

Investigators will measure the pinch strength by placing a pinch meter between the pad of the thumb and pad of the index and middle finger. The investigators will compare the change in 3 point chuck strength between the two cohorts after 12 weeks of treatment.

Time frame:
At enrollment and 12 week follow up
Reported as:
Mean · pounds
Difference in 3-point Chuck Strength at 12 Weeks
poundsSplint OnlySplint With First Dorsal Interosseous (FDI) Strengthening
Difference in 3-point Chuck Strength at 12 Weeks0.708 ± 2.6001.103 ± 2.024
PrimaryDifference in Lateral Pinch Strength at 12 Weeks

The investigators will measure lateral pinch strength by placing a pinch meter between the pad of the thumb and lateral surface of the index finger. The investigators will compare the change in lateral pinch strength between the two cohorts after 12 weeks of treatment.

Time frame:
At enrollment and 12 week follow up
Reported as:
Mean · pounds
Difference in Lateral Pinch Strength at 12 Weeks
poundsSplint OnlySplint With First Dorsal Interosseous (FDI) Strengthening
Difference in Lateral Pinch Strength at 12 Weeks0.458 ± 2.8431.138 ± 3.136
SecondaryVisual Analog Scale (VAS) for Pain

The Visual Analog Scale for Pain measures the amount of pain on a scale from 0, no pain, to 10, worst possible pain. The investigators will compare the change in pain between the two cohorts after 12 weeks of treatment.

Time frame:
At enrollment and 12 week follow up
Reported as:
Mean · points on a scale
Visual Analog Scale (VAS) for Pain
points on a scaleSplint OnlySplint With First Dorsal Interosseous (FDI) Strengthening
Visual Analog Scale (VAS) for Pain-0.89 ± 2.093-0.875 ± 2.584
SecondaryChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks

A computerized assessment of depression measured at enrollment. The average T score of the U.S. population is 50 with a standard deviation of 10, so the T score reported compares the study population to the U.S. population, where a T score greater than 50 is worse than the average and a T score less than 50 is better than the average. The investigators will compare the change in PROMIS Upper Extremity between the two cohorts after 12 weeks of treatment.

Time frame:
At Enrollment and 12 week follow up
Reported as:
Mean · T-score
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks
T-scoreSplint OnlySplint With First Dorsal Interosseous (FDI) Strengthening
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 Weeks0.739 ± 7.2341.202 ± 5.704

Adverse events

Collected over Adverse event data were collected throughout the study participation period, from enrollment through the 12-week follow-up period (11-13 weeks after enrollment).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Splint Only0/80 (0%)0/80 (0%)0/80 (0%)
Splint With First Dorsal Interosseous (FDI) Strengthening0/80 (0%)0/80 (0%)0/80 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Splint OnlySplint With First Dorsal Interosseous (FDI) StrengtheningTotal
Median61 (56 to 71)67 (58 to 72)64 (56 to 72)
Sex: Female, Male
Sex: Female, Male(Participants)Splint OnlySplint With First Dorsal Interosseous (FDI) StrengtheningTotal
Female302454
Male141933
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Splint OnlySplint With First Dorsal Interosseous (FDI) StrengtheningTotal
American Indian or Alaska Native000
Asian213
Native Hawaiian or Other Pacific Islander000
Black or African American101
White394079
More than one race000
Unknown or Not Reported224
Region of Enrollment
Region of Enrollment(participants)Splint OnlySplint With First Dorsal Interosseous (FDI) StrengtheningTotal
United States444387
08

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
09

References and documents

Publications

  • Sodha S, Ring D, Zurakowski D, Jupiter JB. Prevalence of osteoarthrosis of the trapeziometacarpal joint. J Bone Joint Surg Am. 2005 Dec;87(12):2614-2618. doi: 10.2106/JBJS.E.00104. PubMed 16322609 ↗
  • Edmunds JO. Traumatic dislocations and instability of the trapeziometacarpal joint of the thumb. Hand Clin. 2006 Aug;22(3):365-92. doi: 10.1016/j.hcl.2006.05.001. PubMed 16843802 ↗
  • O'Brien VH, Giveans MR. Effects of a dynamic stability approach in conservative intervention of the carpometacarpal joint of the thumb: a retrospective study. J Hand Ther. 2013 Jan-Mar;26(1):44-51; quiz 52. doi: 10.1016/j.jht.2012.10.005. Epub 2012 Nov 21. PubMed 23177671 ↗
  • McGee C, O'Brien V, Van Nortwick S, Adams J, Van Heest A. First dorsal interosseous muscle contraction results in radiographic reduction of healthy thumb carpometacarpal joint. J Hand Ther. 2015 Oct-Dec;28(4):375-80; quiz 381. doi: 10.1016/j.jht.2015.06.002. Epub 2015 Jun 27. PubMed 26209165 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2016 to primary completion in Jun 2025, 102 months.

Results were first posted in Nov 2026, 1 year 5 months after primary completion.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 102 months is above that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2017
First posted
Jun 6, 2017
StartActual
Dec 29, 2016
Primary completionActual
Jun 2025
CompletionActual
Sep 2025
Results first posted
Nov 10, 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 10, 2026
Primary outcomes
1 edited, 3 removed
What changed in the outcomes
  • EditedDifference in 3-point chuck strengthLateral Pinch Strength at 12 weeksWeeksTime frame: At enrollment and 12 week follow up
  • RemovedDifference in Lateral pinch strength at 12 weeksTime frame: At enrollment and 12 week follow up
  • RemovedVisual Analog Scale (VAS) for PainTime frame: At enrollment and 12 week follow up
  • RemovedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 weeksTime frame: At Enrollment and 12 week follow up
Nov 10, 2026
Documents
Secondary outcomes
3 added
What changed in the outcomes
  • AddedDifference in 3-point Chuck Strength at 12 WeeksTime frame: At enrollment and 12 week follow up
  • AddedVisual Analog Scale (VAS) for PainTime frame: At enrollment and 12 week follow up
  • AddedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 WeeksTime frame: At Enrollment and 12 week follow up
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Results posted
    Primary outcomes 1 edited, 3 removed
    What changed in the outcomes
    • EditedDifference in 3-point chuck strengthLateral Pinch Strength at 12 weeksWeeksTime frame: At enrollment and 12 week follow up
    • RemovedDifference in Lateral pinch strength at 12 weeksTime frame: At enrollment and 12 week follow up
    • RemovedVisual Analog Scale (VAS) for PainTime frame: At enrollment and 12 week follow up
    • RemovedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 weeksTime frame: At Enrollment and 12 week follow up
    Secondary outcomes 3 added
    What changed in the outcomes
    • AddedDifference in 3-point Chuck Strength at 12 WeeksTime frame: At enrollment and 12 week follow up
    • AddedVisual Analog Scale (VAS) for PainTime frame: At enrollment and 12 week follow up
    • AddedChange in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 WeeksTime frame: At Enrollment and 12 week follow up
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03177577
Responsible party
Neal Chung-Jen Chen (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Jun 6, 2017
Start date
Dec 29, 2016
Primary completion
Jun 2025
Completion
Sep 2025
Results posted
Nov 10, 2026
Last update
Nov 10, 2026

Study contacts

Neal Chen, MD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion